5 completed, 3 unknown, 1 active not recruiting, 1 recruiting. 4 Phase 3, 3 Phase 2, 1 Phase 1, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Completed 3, Unknown 1 |
| Phase 2 | 3 | Active not recruiting 1, Completed 1, Unknown 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 4 | 1 | Unknown 1 |
Follow Apotex Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Enoxacin for Amyotrophic Lateral Sclerosis (ALS) Enoxacin, Placebo - Amyotrophic Lateral Sclerosis | Phase 1 / Phase 2 | Completed | McGill University | 8 | 2021-03-26 | 2024-01-26 |
| Treatments for COVID-19: Canadian Arm of the SOLIDARITY Trial Artesunate, Imatinib, Infliximab - COVID-19 | Phase 3 | Unknown | Sunnybrook Health Sciences Centre | 2900 | 2020-03-18 | 2023-10-13 |
| ASA in Prevention of Ovarian Cancer (STICs and STONEs) Acetylsalicylic acid, Placebo - Ovarian Cancer Prevention | Phase 2 | Active not recruiting | Canadian Cancer Trials Group | 117 | 2018-07-24 | 2026-09-16 |
| A Study Comparing the Bioequivalence of Azelastine Hydrochloride and Fluticasone Propionate Nasal Spray (Apotex, Inc.) to That of Dymista™ Nasal Spray (Meda Pharmaceuticals, Inc.) in the Treatment of Seasonal Allergic Rhinitis Azelastine HCl and Fluticasone Propionate Nasal Spray, 137 µg/50 µg per spray, Dymista™ Nasal Spray, Placebo - Seasonal Allergic Rhinitis | Phase 2 | Unknown | Apotex Inc. | 595 | 2013-12-01 | 2014-10-31 |
| The Mycophenolate Pregnancy Registry Heart Transplantation, Kidney Transplantation, Liver Transplantation, Autoimmune Diseases | Completed | Genentech, Inc. | 400 | 2012-11-20 | 2026-10-13 | |
| A Study Comparing The Bioequivalence Of Ciclesonide Nasal Spray (Apotex, Inc.) To That Of Omnaris™ Nasal Spray (Sepracor, Inc.) In The Treatment Of Seasonal Allergic Rhinitis Ciclesonide nasal spray, 50 μg per actuation. - Seasonal Allergic Rhinitis | Phase 3 | Completed | Apotex Inc. | 580 | 2011-03-01 | 2014-10-24 |
| A Randomized, Double-Blind, Parallel-Group, Vehicle-Controlled Therapeutic Equivalence Study of Three Imiquimod Cream 5% Treatments for Patients With Actinic Keratosis Imiquimod 5%: manufactured by Apotex, Adara 5% Cream US, Adara 5% Cream Canada - Actinic Keratosis | Phase 3 | Completed | Apotex Inc. | 497 | 2008-02-01 | 2009-03-10 |
| Combined Chelation Treatment With Deferiprone and Deferoxamine in Thalassemia Major deferiprone - Beta-Thalassemia | Phase 4 | Unknown | Royal Brompton & Harefield NHS Foundation Trust | 65 | 2004-05-01 | 2005-06-24 |
| Antiretroviral Pregnancy Registry (APR): Multi-sponsor Registry to Detect Any Major Teratogenic Effect Involving Any of the Registry Drugs When Administered to Pregnant People. HIV Infections, Hepatitis B | Recruiting | Syneos Health | 24258 | 1991-07-21 | 2026-11-19 | |
| A Study Comparing the Bioequivalence of Triamcinolone Acetonide Aqueous Nasal Spray (Apotex, Inc.) to That of Nasacort® AQ Nasal Spray (Sanofi-Aventis Pharmaceutical Products, Inc.) In the Treatment of Seasonal Allergic Rhinitis triamcinolone acetonide aqueous nasal spray (Apotex Inc.), triamcinolone acetonide aqueous nasal spray (Nasacort® AQ), Placebo - Seasonal Allergic Rhinitis | Phase 3 | Completed | Apotex Inc. | 2009-09-30 |
Rhinitis, Allergic, Seasonal (3) · Amyotrophic Lateral Sclerosis (1) · Autoimmune Diseases (1) · COVID-19 (1) · HIV Infections (1) · Hepatitis (1) · Hepatitis B (1) · Keratosis, Actinic (1) · beta-Thalassemia (1)
Artesunate (1) · Aspirin (1) · Deferiprone (1) · Dexamethasone (1) · Enoxacin (1) · Imatinib Mesylate (1) · Imiquimod (1) · Infliximab (1) · azelastine (1)
Canada (3) · United States (3) · Australia (1) · Italy (1)
Amit Oza (1) · Angela Genge, MD, FRCP (1) · Jessica D Albano, PhD, MPH (1) · Srinivas Murthy, MD (1) · Stephanie Lheureux (1) · William Brooks (1)
PMID 18298856, PMID 26269220, PMID 26687320, PMID 33264556, PMID 34350582, PMID 35045989, PMID 35609913, PMID 36036936, PMID 36199248, PMID 36695483